Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 2,734 shares at $87.63 ($240K) on 2024-03-08, disclosed to the SEC on 2024-03-12.
Scheduled sale ($240k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.63 | 1,317 | $115K | 48.1% |
| 2 | $87.63 | 1,317 | $115K | 48.1% |
| 3 | $90.04 | 100 | $9K | 3.8% |
| Total | $87.72 avg | 2,734 | $240K | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |